Cerebellar Astrocytes: Much More Than Passive Bystanders In Ataxia Pathophysiology
Open Access
- 11 March 2020
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (3), 757
- https://doi.org/10.3390/jcm9030757
Abstract
Ataxia is a neurodegenerative syndrome, which can emerge as a major element of a disease or represent a symptom of more complex multisystemic disorders. It comprises several forms with a highly variegated etiology, mainly united by motor, balance, and speech impairments and, at the tissue level, by cerebellar atrophy and Purkinje cells degeneration. For this reason, the contribution of astrocytes to this disease has been largely overlooked in the past. Nevertheless, in the last few decades, growing evidences are pointing to cerebellar astrocytes as crucial players not only in the progression but also in the onset of distinct forms of ataxia. Although the current knowledge on this topic is very fragmentary and ataxia type-specific, the present review will attempt to provide a comprehensive view of astrocytes’ involvement across the distinct forms of this pathology. Here, it will be highlighted how, through consecutive stage-specific mechanisms, astrocytes can lead to non-cell autonomous neurodegeneration and, consequently, to the behavioral impairments typical of this disease. In light of that, treating astrocytes to heal neurons will be discussed as a potential complementary therapeutic approach for ataxic patients, a crucial point provided the absence of conclusive treatments for this disease.Keywords
This publication has 131 references indexed in Scilit:
- Reelin is a target of polyglutamine expanded ataxin-7 in human spinocerebellar ataxia type 7 (SCA7) astrocytesProceedings of the National Academy of Sciences of the United States of America, 2012
- ATM kinase inhibition in glial cells activates the innate immune response and causes neurodegeneration inDrosophilaProceedings of the National Academy of Sciences of the United States of America, 2012
- Glial S100B Protein Modulates Mutant Ataxin-1 Aggregation and Toxicity: TRTK12 Peptide, a Potential Candidate for SCA1 TherapyThe Cerebellum, 2011
- Loss of adenomatous polyposis coli in Bergmann glia disrupts their unique architecture and leads to cell nonautonomous neurodegeneration of cerebellar Purkinje neuronsGlia, 2011
- Suppression of the novel ER protein Maxer by mutant ataxin-1 in Bergman glia contributes to non-cell-autonomous toxicityThe EMBO Journal, 2010
- Huwe1 ubiquitin ligase is essential to synchronize neuronal and glial differentiation in the developing cerebellumProceedings of the National Academy of Sciences of the United States of America, 2010
- Bergmann Glial S100B Activates Myo-inositol Monophosphatase 1 and Co-localizes to Purkinje Cell Vacuoles in SCA1 Transgenic MiceThe Cerebellum, 2009
- Oxidative Stress Is Linked to ERK1/2-p16 Signaling-mediated Growth Defect in ATM-deficient AstrocytesPublished by Elsevier BV ,2009
- Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyteProceedings of the National Academy of Sciences of the United States of America, 2009
- Astrocyte‐only Npc1 reduces neuronal cholesterol and triples life span of Npc1–/– miceJournal of Neuroscience Research, 2008